Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient

被引:6
|
作者
Wandeler, Gilles [1 ,2 ]
Furrer, Hansjakob [1 ]
Rauch, Andri [1 ]
机构
[1] Univ Bern, Univ Hosp Bern, Univ Clin Infect Dis, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland
关键词
ANTIRETROVIRAL THERAPY; INTEGRASE INHIBITORS; DRUG-RESISTANCE; HIV-2; INDIVIDUALS; SENEGAL; PREDICT;
D O I
10.1097/QAD.0b013e32834cdb89
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2306 / 2308
页数:3
相关论文
共 50 条
  • [21] Raltegravir treatment response in an HIV-2 infected patient: a case report
    Garrett, Nigel
    Xu, Li
    Smit, Erasmus
    Ferns, Bridget
    El-Gadi, Saleh
    Anderson, Jane
    AIDS, 2008, 22 (09) : 1091 - 1092
  • [22] Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens
    Garrido, Carolina
    Villacian, Jorge
    Zahonero, Natalia
    Pattery, Theresa
    Garcia, Federico
    Gutierrez, Felix
    Caballero, Estrella
    Van Houtte, Margriet
    Soriano, Vincent
    de Mendoza, Carmen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2873 - 2878
  • [23] Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naive HIV-2-infected patient
    Zheng, Yue
    Lambert, Christine
    Arendt, Vic
    Seguin-Devaux, Carole
    AIDS, 2014, 28 (15) : 2329 - 2331
  • [24] Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis
    Meyers, Tammy
    Samson, Pearl
    Acosta, Edward P.
    Moye, Jack
    Townley, Ellen
    Bradford, Sarah
    Marillo, Linda
    Denson, Kayla
    Hovind, Laura
    Sise, Thucuma
    Teppler, Hedy
    Mathiba, Sisinyana Ruth
    Masenya, Masebole
    Hesseling, Anneke
    Cotton, Mark F.
    Krogstad, Paul
    AIDS, 2019, 33 (14) : 2197 - 2203
  • [25] HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens
    da Silva, Daniel
    Van Wesenbeeck, Liesbeth
    Breilh, Dominique
    Reigadas, Sandrine
    Anies, Guerric
    Van Baelen, Kurt
    Morlat, Philippe
    Neau, Didier
    Dupon, Michel
    Wittkop, Linda
    Fleury, Herve
    Masquelier, Bernard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1262 - 1269
  • [26] Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients
    Larrouy, L.
    Vivot, A.
    Charpentier, C.
    Benard, A.
    Damond, F.
    Matheron, S.
    Chene, G.
    Brun-Vezinet, F.
    Descamps, D.
    ANTIVIRAL THERAPY, 2011, 16 : A13 - A13
  • [27] Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients
    Larrouy, Lucile
    Vivot, Alexandre
    Charpentier, Charlotte
    Benard, Antoine
    Visseaux, Benoit
    Damond, Florence
    Matheron, Sophie
    Chene, Genevieve
    Brun-Vezinet, Francoise
    Descamps, Diane
    AIDS, 2013, 27 (01) : 69 - 80
  • [28] Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen
    Armenia, D.
    Malet, I.
    Fabeni, L.
    Reigadas, S.
    Guillot, V.
    Dunn, D.
    Kaiser, R.
    Zazzi, M.
    Van Laethem, K.
    Artese, A.
    Garrido, C.
    Masquelier, B.
    Garcia, F.
    Calvez, V.
    Antinori, A.
    Marcelin, A. G.
    Perno, C. F.
    Geretti, A. M.
    Ceccherini-Silberstein, F.
    ANTIVIRAL THERAPY, 2011, 16 : A69 - A69
  • [30] Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era
    Ronchetti, Anne-Marie
    Matheron, Sophie
    Galicier, Lionel
    Damond, Florence
    Mahjoub, Nadia
    Chaghil, Nathalie
    Meignin, Veronique
    Mechai, Frederic
    Simon, Francois
    Oksenhendler, Eric
    Gerard, Laurence
    AIDS, 2021, 35 (14) : 2299 - 2309